Sign In
Buy BHVN
$15.55
-1.24 (-7.39%)
At Close: Jul 10, 2026
Biohaven Pharmaceutical Holding Company Ltd. Expected to Post FY2021 Earnings of ($9.88) Per Share (NYSE:BHVN)
07:32am, Tuesday, 16'th Nov 2021 Transcript Daily
Biohaven Pharmaceutical Holding Company Ltd. (NYSE:BHVN) Stock analysts at Cantor Fitzgerald increased their FY2021 EPS estimates for Biohaven Pharmaceutical in a research report issued on Wednesday, November 10th. Cantor Fitzgerald analyst C. Duncan now expects that the company will earn ($9.88) per share for the year, up from their previous estimate of ($12.25). Cantor []
Biohaven Completes Enrollment Of Verdiperstat Arm Of Pivotal Healey ALS Platform Trial Conducted By The Healey Center For ALS At Massachussetts General Hospital
01:00pm, Monday, 15'th Nov 2021 PR Newswire
NEW HAVEN, Conn., Nov. 15, 2021 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) ("Biohaven") announced today that enrollment is now complete in the verdiperstat arm of the HEALEY ALS Platform Trial. This first-ever platform trial in ALS, sponsored by the Sean M.
